You are here

Axitinib

Phase II Fail Prompts Acceleron to Discontinue Development of Renal Cell Carcinoma Drug

Xtalks

Thu, 06/15/17 - 09:39 am

renal cell carcinoma

clinical trials

Pfizer (PFE) Gets Favorable Outcome for Axitinib from FDA Committee

StreetInsider.com

Wed, 12/7/11 - 11:50 am

advisory panels

renal cell carcinoma

Pfizer’s Kidney Cancer Drug May Not Be Effective, FDA Says

Bloomberg

Mon, 12/5/11 - 09:31 am

Pfizer says it asked European Union to approve its kidney cancer drug candidate axitinib

Yahoo/AP

Wed, 06/1/11 - 07:49 am

Pfizer's Axitinib Encourages

Yahoo/Zacks

Sat, 05/21/11 - 11:14 am

renal cell carcinoma

Pfizer Goes for a One-Two Blockbuster Knockout

Motley Fool

Fri, 05/20/11 - 09:42 am

ONYX Pharmaceuticals

Experimental Pfizer Drug Slows Kidney Cancer in Large Trial

Bloomberg

Thu, 05/19/11 - 09:48 am

Pfizer's Mixed Bag

Motley Fool

Tue, 11/23/10 - 08:55 am

Boehringer Ingelheim

Bristol-Myers Squibb

Pfizer Says Axitinib Trial Met its Primary Endpoint

Bloomberg

Fri, 11/19/10 - 01:38 pm

clinical trials